Drug & intervention
clevidipine
RxCUI 233603
RxNorm ingredient and formulation relationships
Source-verified product relationships. Every strength, delivery form and RxCUI remains a separate clinical concept.
Loading RxNorm relationships…
Background context
Clevidipine
Clevidipine (INN, trade name Cleviprex) is a dihydropyridine calcium channel blocker indicated for the reduction of blood pressure when oral therapy is not feasible or not desirable. Clevidipine is used IV only and practitioners titrate this drug to lower blood pressure. It has a half-life of approximately one minute. It is rapidly inactivated by esterases. It was approved by the United States Food and Drug Administration on August 1, 2008.
Background only. Canonical identity remains RxNorm; clinical-trial relationships come from ClinicalTrials.gov.Clinical trials
13 shownEffect of Treatment of Pre-induction Hypertension on Hemodynamic Stability During Induction of General AnesthesiaNCT06063772 · 2025-01-01
NOT_YET_RECRUITINGThe Evaluation of Clevidipine in Patients Requiring ICP Monitoring and IV Antihypertensive TherapyNCT01910532 · 2010-04-01
WITHDRAWNClevidipine for Vasoreactivity Evaluation of the Pulmonary Arterial BedNCT01121458 · 2009-09-01
COMPLETEDA Pilot Study to Evaluate Efficacy and Safety of Clevidipine in Neurosurgical PatientsNCT00952081 · 2009-07-01
COMPLETEDClevidipine in the Treatment of Blood Pressure in Patients With Acute Heart Failure (PRONTO)NCT00803634 · 2008-12-01
COMPLETEDClevidipine Bolus Administration in the Treatment of Hypertensive Patients Undergoing Cardiac Surgery (SPRINT)NCT00799604 · 2008-11-01
COMPLETEDClevidipine in the Treatment of Patients With Acute Hypertension and Intracerebral Hemorrhage (ACCELERATE)NCT00666328 · 2008-06-01
COMPLETEDClevidipine in the Treatment of Patients With Severe Hypertension (VELOCITY)NCT00369837 · 2006-09-01
COMPLETEDClevidipine in the Perioperative Treatment of Hypertension (ECLISPE-SNP)NCT00093912 · 2004-06-01
COMPLETEDClevidipine in the Postoperative Treatment of Hypertension (ECLIPSE-NIC)NCT00093925 · 2004-05-01
COMPLETEDClevidipine in the Perioperative Treatment of Hypertension (ECLIPSE-NTG)NCT00093886 · 2004-04-01
COMPLETEDStudy of Clevidipine Assessing Its Preoperative Antihypertensive Effect in Cardiac Surgery (ESCAPE-1)NCT00093249 · 2004-01-01
COMPLETEDStudy of Clevidipine Assessing Its Postoperative Antihypertensive Effect in Cardiac Surgery (ESCAPE-2)NCT00093262 · 2003-12-01
COMPLETEDConditions being studied
Research locations
New YorkNew York, United States6HoustonTexas, United States5PhiladelphiaPennsylvania, United States5CincinnatiOhio, United States4Los AngelesCalifornia, United States4New OrleansLouisiana, United States4WichitaKansas, United States4BirminghamAlabama, United States3ClevelandOhio, United States3DetroitMichigan, United States3DurhamNorth Carolina, United States3HonoluluHawaii, United States3
Leading sponsors
Drug identity and terminology: RxNorm. Trial relationships: ClinicalTrials.gov.